BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24722564)

  • 1. Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2.
    Perfetti A; Greco S; Fasanaro P; Bugiardini E; Cardani R; Garcia-Manteiga JM; Riba M; Cittaro D; Stupka E; Meola G; Martelli F
    PLoS One; 2014; 9(4):e93983. PubMed ID: 24722564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
    Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2.
    Cardani R; Baldassa S; Botta A; Rinaldi F; Novelli G; Mancinelli E; Meola G
    Neuromuscul Disord; 2009 May; 19(5):335-43. PubMed ID: 19345584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions.
    Screen M; Jonson PH; Raheem O; Palmio J; Laaksonen R; Lehtimäki T; Sirito M; Krahe R; Hackman P; Udd B
    Am J Pathol; 2014 Aug; 184(8):2322-32. PubMed ID: 24907641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy.
    Fugier C; Klein AF; Hammer C; Vassilopoulos S; Ivarsson Y; Toussaint A; Tosch V; Vignaud A; Ferry A; Messaddeq N; Kokunai Y; Tsuburaya R; de la Grange P; Dembele D; Francois V; Precigout G; Boulade-Ladame C; Hummel MC; Lopez de Munain A; Sergeant N; Laquerrière A; Thibault C; Deryckere F; Auboeuf D; Garcia L; Zimmermann P; Udd B; Schoser B; Takahashi MP; Nishino I; Bassez G; Laporte J; Furling D; Charlet-Berguerand N
    Nat Med; 2011 Jun; 17(6):720-5. PubMed ID: 21623381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flies deficient in Muscleblind protein model features of myotonic dystrophy with altered splice forms of Z-band associated transcripts.
    Machuca-Tzili L; Thorpe H; Robinson TE; Sewry C; Brook JD
    Hum Genet; 2006 Nov; 120(4):487-99. PubMed ID: 16927100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2.
    Cardani R; Bugiardini E; Renna LV; Rossi G; Colombo G; Valaperta R; Novelli G; Botta A; Meola G
    PLoS One; 2013; 8(12):e83777. PubMed ID: 24376746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.
    Vihola A; Bachinski LL; Sirito M; Olufemi SE; Hajibashi S; Baggerly KA; Raheem O; Haapasalo H; Suominen T; Holmlund-Hampf J; Paetau A; Cardani R; Meola G; Kalimo H; Edström L; Krahe R; Udd B
    Acta Neuropathol; 2010 Apr; 119(4):465-79. PubMed ID: 20066428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2.
    Botta A; Vallo L; Rinaldi F; Bonifazi E; Amati F; Biancolella M; Gambardella S; Mancinelli E; Angelini C; Meola G; Novelli G
    Gene Expr; 2007; 13(6):339-51. PubMed ID: 17708420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2.
    Raheem O; Olufemi SE; Bachinski LL; Vihola A; Sirito M; Holmlund-Hampf J; Haapasalo H; Li YP; Udd B; Krahe R
    Am J Pathol; 2010 Dec; 177(6):3025-36. PubMed ID: 20971734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2.
    Santoro M; Masciullo M; Bonvissuto D; Bianchi ML; Michetti F; Silvestri G
    Mol Cell Biochem; 2013 Aug; 380(1-2):259-65. PubMed ID: 23666741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2.
    Cardani R; Giagnacovo M; Rossi G; Renna LV; Bugiardini E; Pizzamiglio C; Botta A; Meola G
    Neuromuscul Disord; 2014 Dec; 24(12):1042-53. PubMed ID: 25139674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1.
    Koebis M; Ohsawa N; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Genes Cells; 2011 Sep; 16(9):961-72. PubMed ID: 21794030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
    Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
    Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression.
    Margolis JM; Schoser BG; Moseley ML; Day JW; Ranum LP
    Hum Mol Genet; 2006 Jun; 15(11):1808-15. PubMed ID: 16624843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.
    Bachinski LL; Baggerly KA; Neubauer VL; Nixon TJ; Raheem O; Sirito M; Unruh AK; Zhang J; Nagarajan L; Timchenko LT; Bassez G; Eymard B; Gamez J; Ashizawa T; Mendell JR; Udd B; Krahe R
    Neuromuscul Disord; 2014 Mar; 24(3):227-40. PubMed ID: 24332166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.
    Tang ZZ; Yarotskyy V; Wei L; Sobczak K; Nakamori M; Eichinger K; Moxley RT; Dirksen RT; Thornton CA
    Hum Mol Genet; 2012 Mar; 21(6):1312-24. PubMed ID: 22140091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes.
    Santoro M; Piacentini R; Masciullo M; Bianchi ML; Modoni A; Podda MV; Ricci E; Silvestri G; Grassi C
    Neuropathol Appl Neurobiol; 2014 Jun; 40(4):464-76. PubMed ID: 23888875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.